Showing results (21-30 of 76) with videos related to
Sort By:
Pageof 8
The Journal of Experimental Medicine|March 1, 1990
A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic functionA Moretta, G Tambussi, C Bottino, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1995
Epidemic HIV-related Kaposi's sarcoma: a retrospective analysis and validation of TIS staging. GICAT. Gruppo Italiano Collaborativo AIDS e TumoriG Tambussi, L Repetto, V Torri, et al.Clinical Immunology (Orlando, Fla.)|April 5, 2001
Expression and activation of a C-terminal truncated isoform of STAT5 (STAT5 Delta) following interleukin 2 administration or AZT monotherapy in HIV-infected individualsC Bovolenta, L Camorali, M Mauri, et al.European Journal of Immunology|January 1, 1989
Monoclonal antibodies which react with the T cell receptor gamma/delta recognize different subsets of CD3+WT31- T lymphocytesS Ferrini, I Prigione, C Bottino, et al.The Journal of Experimental Medicine|July 1, 1988
Human cytolytic cell clones lacking surface expression of T cell receptor alpha/beta or gamma/delta. Evidence that surface structures other than CD3 or CD2 molecules are required for signal transductionG Pantaleo, M R Zocchi, S Ferrini, et al.International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1989
Surface molecules involved in CD3-negative NK cell function. A novel molecule which regulates the activation of a subset of human NK cellsA Moretta, E Ciccone, G Tambussi, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 10, 1999
In vivo administration of recombinant IL-2 to individuals infected by HIV down-modulates the binding and expression of the transcription factors ying-yang-1 and leader binding protein-1/late simian virus 40 factorC Bovolenta, L Camorali, A L Lorini, et al.AIDS (London, England)|June 5, 1999
Viral load and burden modification following early antiretroviral therapy of primary HIV-1 infectionF B Lillo, D Ciuffreda, F Veglia, et al.The Journal of Experimental Medicine|August 1, 1988
Two subsets of human T lymphocytes expressing gamma/delta antigen receptor are identifiable by monoclonal antibodies directed to two distinct molecular forms of the receptorC Bottino, G Tambussi, S Ferrini, et al.Journal of Biological Regulators and Homeostatic Agents|April 14, 2000
Analysis of serum and plasma beta chemokines in primary HIV infection (PHI)M S Malnati, G Tambussi, L Fischetti, et al.Pageof 8